We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Human Brain Cells Grown in Mice Could Lead to Alzheimer's Therapy

Human Brain Cells Grown in Mice Could Lead to Alzheimer's Therapy

Human Brain Cells Grown in Mice Could Lead to Alzheimer's Therapy

Human Brain Cells Grown in Mice Could Lead to Alzheimer's Therapy

The image on the left shows that in the chimeric mouse brain, the hippocampus, a brain region highly associated with learning and memory functions, is nearly completely populated by implanted human stem cell-derived microglia. The image on the right gives a closer look at the human stem cell-derived microglia grown in mouse brain. Credit: Rutgers University
Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Human Brain Cells Grown in Mice Could Lead to Alzheimer's Therapy"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A novel study involving human brain cells grown in mice provides insight that could lead to potential therapy.

Rutgers scientists have found more clear-cut evidence of how the destructive proteins linked to Alzheimer’s disease attack human brain cells and destroy surrounding tissue.

In one of the first studies of its kind examining human brain cells grown in a mouse brain, researchers identified a pivotal mechanism that could be a potential therapeutic target for a disease that afflicts millions and has no known cure.

Writing in the journal Cell Stem Cell, the researchers described experiments studying human brain immune cells injected into the brains of specially bred immunodeficient mice, creating what they called a human-mouse chimera. They detailed what happened to specialized immune brain cells known as microglia after those cells were exposed to tau proteins -- destructive substances believed to be involved in Alzheimer’s and other severe human brain diseases.

“In this study, we used our newly developed chimeric mouse brain model – where human cells are injected and allowed to grow, develop and mature with appropriate functions in a live mouse brain,” said Peng Jiang, an associate professor in the Department of Cell Biology and Neuroscience at the Rutgers School of Arts and Sciences. “This provided an unprecedented opportunity to investigate the role of human microglia in brains as well as the cognitive impairment seen in Alzheimer’s Disease and Down syndrome, a genetic disorder with a high risk of developing Alzheimer’s disease.”

By studying the process in the human-mouse brain chimera, the scientists were able to witness and analyze – through samples extracted at different stages – a cellular brain attack that has been largely elusive up to this point.

In autopsies, scientists have been able to study the brains of people who died from Alzheimer’s and have seen residues of tau proteins, cellular changes, and some other possible causative factors. The human-mouse brain chimera has allowed the Rutgers team to extract and see human cells in the actual process of deterioration.

The mice in the study were specially bred to be immunodeficient so that they could receive implanted human cells without rejecting them due to normal immune defenses.  The immunodeficient mice were injected with human microglial cells and, later, with tau proteins, which are linked to the development of the brain disease.

“Since microglial cells are one of the first cell responders when something goes wrong in the brain, we believe the changes we saw to be significant,” said Mengmeng Jin, a postdoctoral researcher in the Department of Cell Biology and Neuroscience at Rutgers and first author on the study.

A genetic analysis also showed genes involved in interferon signaling turning on during the attack, indicating an important area to target for future therapies.

Reference: Jin M, Xu R, Wang L, et al. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer’s disease. Cell Stem Cell. 2022;29(7):1135-1153.e8. doi:10.1016/j.stem.2022.06.007

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.